In summary, the current studies demonstrate a strong association between reduced CEACAM1 expression in hepatocytes with obesity, hepatic steatosis, and dyslipidemia across species and multiple rat strains. This evidence concerns the gene CEACAM1 and obesity due to melanocortin 4 receptor deficiency.